Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine citrate versus placebo for emergence after outpatient pediatric surgery under sevoflurane anesthesia
IRCT20190511043550N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of caffeine in Anesthesia-related recovery impairment (ARRI) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Emergence, Systolic blood pressure and 1 more. Started Jun 2019; status: completed.
02
Drugs
caffeine
03
Conditions
Anesthesia-related recovery impairment (ARRI)
Beyond the preview
Go deeper on IRCT20190511043550N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190511043550N1.